NEU 2.50% $15.59 neuren pharmaceuticals limited

Daybue Rollout, page-30

  1. 2,030 Posts.
    lightbulb Created with Sketch. 478
    Hmmm, interesting point Flash, once a significant population of Rett sufferers are on Daybue, how very much more difficult does the task of recruitment become for further Rett studies/trials in the US?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.